Just as other adipokines, a growing body of research has shown that elevated RBP4 levels were positively correlated with obesity-linked complications including impaired glucose tolerance, insulin resistance, type 2 diabetes mellitus, dyslipidemia, hypertension and cardiovascular diseases[20–22]. Here, RBP4 is linked to obesity disorder.